MEP11809A - Indole compound - Google Patents
Indole compoundInfo
- Publication number
- MEP11809A MEP11809A MEP-118/09A MEP11809A MEP11809A ME P11809 A MEP11809 A ME P11809A ME P11809 A MEP11809 A ME P11809A ME P11809 A MEP11809 A ME P11809A
- Authority
- ME
- Montenegro
- Prior art keywords
- indole compound
- present
- glucokinase activator
- prodrug
- prophylaxis
- Prior art date
Links
- -1 Indole compound Chemical class 0.000 title 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 title 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 title 1
- 229940124828 glucokinase activator Drugs 0.000 abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006285551 | 2006-10-19 | ||
| PCT/JP2007/070772 WO2008050821A1 (en) | 2006-10-19 | 2007-10-18 | Indole compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ME00681B ME00681B (me) | 2011-12-20 |
| MEP11809A true MEP11809A (en) | 2011-12-20 |
Family
ID=39010108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-118/09A MEP11809A (en) | 2006-10-19 | 2007-10-18 | Indole compound |
Country Status (26)
| Country | Link |
|---|---|
| US (4) | US8410087B2 (enExample) |
| EP (2) | EP2508524A3 (enExample) |
| JP (1) | JP5260507B2 (enExample) |
| KR (1) | KR101444486B1 (enExample) |
| CN (1) | CN101573357B (enExample) |
| AU (1) | AU2007310064B2 (enExample) |
| BR (1) | BRPI0717722A2 (enExample) |
| CA (1) | CA2666973C (enExample) |
| CL (1) | CL2008001017A1 (enExample) |
| CR (1) | CR10748A (enExample) |
| EC (1) | ECSP099330A (enExample) |
| GE (1) | GEP20115241B (enExample) |
| IL (1) | IL198154A (enExample) |
| MA (1) | MA30890B1 (enExample) |
| ME (1) | MEP11809A (enExample) |
| MX (1) | MX2009003972A (enExample) |
| MY (1) | MY158052A (enExample) |
| NO (1) | NO20091948L (enExample) |
| NZ (1) | NZ576570A (enExample) |
| PE (1) | PE20090884A1 (enExample) |
| RU (1) | RU2454415C9 (enExample) |
| TN (1) | TN2009000129A1 (enExample) |
| TW (1) | TWI460176B (enExample) |
| UA (1) | UA97257C2 (enExample) |
| WO (1) | WO2008050821A1 (enExample) |
| ZA (1) | ZA200902585B (enExample) |
Families Citing this family (84)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2682356C (en) * | 2007-04-16 | 2016-06-14 | Abbott Laboratories | 7-substituted indole mcl-1 inhibitors |
| JPWO2008136428A1 (ja) | 2007-04-27 | 2010-07-29 | 武田薬品工業株式会社 | 含窒素５員複素環化合物 |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| JP5517935B2 (ja) * | 2007-08-17 | 2014-06-11 | エルジー・ライフ・サイエンシーズ・リミテッド | 細胞壊死阻害剤としてのインドール及びインダゾール化合物 |
| EP2220081A4 (en) * | 2007-12-20 | 2011-08-24 | Lg Life Sciences Ltd | GLUCCOAINEACTIVATORS AND THESE PHARMACEUTICAL COMPOSITIONS CONTAINING ACTIVE SUBSTANCES |
| CN101952281B (zh) * | 2008-01-04 | 2014-04-02 | 株式会社Lg生命科学 | 具有细胞、组织及器官保存效果的吲哚及吲唑衍生物 |
| WO2009097995A1 (de) * | 2008-02-07 | 2009-08-13 | Sanofi-Aventis | Neue phenyl-substituierte imidazolidine, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2009125873A1 (en) | 2008-04-10 | 2009-10-15 | Takeda Pharmaceutical Company Limited | Fused ring compounds and use thereof |
| WO2009128481A1 (ja) * | 2008-04-16 | 2009-10-22 | 武田薬品工業株式会社 | 含窒素５員複素環化合物 |
| AR072297A1 (es) | 2008-06-27 | 2010-08-18 | Novartis Ag | Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona. |
| WO2010021686A1 (en) * | 2008-08-18 | 2010-02-25 | Promega Corporation | Luminogenic compounds and methods to detect cytochrome p450 3a enzymes |
| TW201014850A (en) | 2008-09-25 | 2010-04-16 | Takeda Pharmaceutical | Solid pharmaceutical composition |
| JP5535931B2 (ja) | 2008-10-27 | 2014-07-02 | 武田薬品工業株式会社 | 二環性化合物 |
| WO2010076884A1 (ja) | 2008-12-29 | 2010-07-08 | 武田薬品工業株式会社 | 新規縮合環化合物およびその用途 |
| WO2010117085A1 (en) * | 2009-04-09 | 2010-10-14 | Banyu Pharmaceutical Co.,Ltd. | Aryl indole derivatives |
| US20120172351A1 (en) | 2009-06-09 | 2012-07-05 | Nobuyuki Negoro | Novel fused cyclic compound and use thereof |
| AU2010279171A1 (en) | 2009-07-28 | 2012-03-01 | Takeda Pharmaceutical Company Limited | Tablet |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| TW201206911A (en) | 2010-04-27 | 2012-02-16 | Takeda Pharmaceutical | Bicyclic compound |
| BR112012032055B8 (pt) | 2010-06-16 | 2019-11-12 | Takeda Pharmaceuticals Co | cristal de cloridrato de 1-(4-metoxibutil)-n-(2-metilpropil)-n-[(3s,5r)-5-(morfolin-4-ilcarbonil)piperidin-3-il]-1h-benzimidazol-2-carboxamida, medicamento, e, uso do cristal |
| WO2011159781A2 (en) * | 2010-06-17 | 2011-12-22 | Senomyx, Inc. | Bitter taste modulators |
| US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| JP5816626B2 (ja) | 2010-09-17 | 2015-11-18 | 武田薬品工業株式会社 | 糖尿病治療剤 |
| AR084032A1 (es) | 2010-11-30 | 2013-04-17 | Takeda Pharmaceutical | Compuesto biciclico |
| AU2012218401A1 (en) | 2011-02-17 | 2013-09-05 | Takeda Pharmaceutical Company Limited | Production method of optically active dihydrobenzofuran derivative |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| WO2013057944A1 (ja) * | 2011-10-19 | 2013-04-25 | 興和株式会社 | 新規なスピロインドリン化合物、及びそれを含有する医薬 |
| JPWO2013061962A1 (ja) | 2011-10-24 | 2015-04-02 | 武田薬品工業株式会社 | 二環性化合物 |
| EP2802571A1 (en) | 2012-01-12 | 2014-11-19 | Takeda Pharmaceutical Company Limited | Benzimidazole derivatives as mch receptor antagonists |
| US9181186B2 (en) | 2012-02-13 | 2015-11-10 | Takeda Pharmaceutical Company Limited | Aromatic ring compound |
| WO2013122028A1 (ja) | 2012-02-13 | 2013-08-22 | 武田薬品工業株式会社 | 芳香環化合物 |
| JP6077555B2 (ja) | 2012-02-15 | 2017-02-08 | 武田薬品工業株式会社 | 錠剤 |
| CN104254525B (zh) | 2012-02-24 | 2016-05-25 | 武田药品工业株式会社 | 芳环化合物 |
| US9073864B2 (en) | 2012-03-29 | 2015-07-07 | Takeda Pharmaceutical Company Limted | Aromatic ring compound |
| WO2013155223A1 (en) * | 2012-04-10 | 2013-10-17 | The Regents Of The University Of California | Compositions and methods for treating cancer |
| EP2848621A4 (en) | 2012-05-10 | 2016-06-01 | Takeda Pharmaceutical | AROMATIC RING CONNECTION |
| JPWO2013168760A1 (ja) | 2012-05-10 | 2016-01-07 | 武田薬品工業株式会社 | 芳香環化合物 |
| EP2854772A1 (en) | 2012-06-05 | 2015-04-08 | Takeda Pharmaceutical Company Limited | Solid preparation |
| JP2015127299A (ja) | 2012-07-19 | 2015-07-09 | 武田薬品工業株式会社 | 固形製剤 |
| WO2014085486A2 (en) | 2012-11-30 | 2014-06-05 | Waters Technologies Corporation | Methods and apparatus for the analysis of vitamin d metabolites |
| US9605000B2 (en) | 2013-03-14 | 2017-03-28 | Takeda Pharmaceutical Company Limited | Spiro azetidine isoxazole derivatives and their use as SSTR antagonists |
| WO2014165816A1 (en) | 2013-04-05 | 2014-10-09 | North Carolina Central University | Compounds useful for the treatment of metabolic disorders and synthesis of the same |
| CN105358544A (zh) | 2013-07-09 | 2016-02-24 | 武田药品工业株式会社 | 杂环化合物 |
| SI3031799T1 (en) | 2013-08-09 | 2018-07-31 | Takeda Pharmaceutical Company Limited | Aromatic compound |
| JP6471163B2 (ja) * | 2013-08-22 | 2019-02-13 | エルジー・ケム・リミテッド | 細胞壊死阻害剤としてのインドールアミド化合物 |
| JO3442B1 (ar) | 2013-10-07 | 2019-10-20 | Takeda Pharmaceuticals Co | مضادات ذات نوع فرعي من مستقبل سوماتوستاتين 5 (sstr5) |
| US9346776B2 (en) | 2014-02-13 | 2016-05-24 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound |
| US9428470B2 (en) | 2014-02-13 | 2016-08-30 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| CN104098498A (zh) * | 2014-07-30 | 2014-10-15 | 天津市斯芬克司药物研发有限公司 | 一种吲唑类化合物及其制备方法 |
| JOP20180029A1 (ar) | 2017-03-30 | 2019-01-30 | Takeda Pharmaceuticals Co | مركب حلقي غير متجانس |
| AR111199A1 (es) | 2017-03-31 | 2019-06-12 | Takeda Pharmaceuticals Co | Compuesto aromático agonista de gpr40 |
| EP3604267A4 (en) | 2017-03-31 | 2020-12-16 | Takeda Pharmaceutical Company Limited | Aromatic compound |
| JOP20180028A1 (ar) | 2017-03-31 | 2019-01-30 | Takeda Pharmaceuticals Co | مركب ببتيد |
| IL277495B2 (en) | 2018-03-23 | 2024-08-01 | Carmot Therapeutics Inc | Modulators of protein-coupled receptors - G |
| EP3650440A4 (en) | 2018-08-27 | 2020-11-25 | Scohia Pharma, Inc. | BENZOIC ESTER COMPOUND |
| JP7511548B2 (ja) | 2018-09-24 | 2024-07-05 | 武田薬品工業株式会社 | Ｇｉｐ受容体アゴニストペプチド化合物及びその使用 |
| EP3856768A2 (en) | 2018-09-24 | 2021-08-04 | Takeda Pharmaceutical Company Limited | Gip receptor agonist peptide compounds and uses thereof |
| CN109250963B (zh) * | 2018-09-29 | 2021-07-16 | 福建省昊立建设工程有限公司 | 一种复合增韧混凝土及其制备方法 |
| CN119874775A (zh) | 2020-02-07 | 2025-04-25 | 加舒布鲁姆生物公司 | 杂环glp-1激动剂 |
| JP2023524603A (ja) | 2020-03-25 | 2023-06-12 | 武田薬品工業株式会社 | Ｇｉｆ受容体アゴニストペプチド化合物及びその使用 |
| PH12022552562A1 (en) | 2020-03-25 | 2022-12-19 | Takeda Pharmaceuticals Co | Qd dosing of gip receptor agonist peptide compounds and uses thereof |
| CN113563306B (zh) * | 2020-04-28 | 2022-07-01 | 新发药业有限公司 | 一种2-(4-苯氧基苯基)-6-(哌啶-4-)基烟酰胺的制备方法 |
| EP4337682A2 (en) | 2021-05-13 | 2024-03-20 | Carmot Therapeutics Inc. | Modulators of g-protein coupled receptors |
| CN119137124A (zh) | 2022-03-09 | 2024-12-13 | 加舒布鲁姆生物公司 | 杂环glp-1激动剂 |
| WO2023179542A1 (en) | 2022-03-21 | 2023-09-28 | Gasherbrum Bio , Inc. | 5,8-dihydro-1,7-naphthyridine derivatives as glp-1 agonists for the treatment of diabetes |
| US20250250269A1 (en) | 2022-04-14 | 2025-08-07 | Gasherbrum Bio, Inc. | Heterocyclic glp-1 agonists |
| EP4634180A1 (en) | 2022-12-15 | 2025-10-22 | Gasherbrum Bio, Inc. | Salts and solid forms of a compound having glp-1 agonist activity |
| CN120693338A (zh) | 2022-12-22 | 2025-09-23 | 加舒布鲁姆生物公司 | 杂环的glp-1激动剂 |
| WO2024131869A1 (en) | 2022-12-22 | 2024-06-27 | Gasherbrum Bio, Inc. | Heterocyclic glp-1 agonists |
| KR20250168210A (ko) | 2023-02-16 | 2025-12-02 | 가셔브룸 바이오, 인크. | 헤테로시클릭 glp-1 효능제 |
| WO2025006921A1 (en) | 2023-06-30 | 2025-01-02 | Gasherbrum Bio, Inc. | Heterocyclic glp-1 agonists |
| WO2025015268A1 (en) | 2023-07-13 | 2025-01-16 | Aconcagua Bio, Inc. | Modulators of calcitonin receptor and/or amylin receptor activity |
| AR133241A1 (es) | 2023-07-13 | 2025-09-10 | Aconcagua Bio Inc | Compuestos, composiciones y métodos |
| WO2025045208A1 (en) | 2023-08-31 | 2025-03-06 | Gasherbrum Bio, Inc. | Heteroaryl-heterocycloalkyl-based glp-1 agonists |
| US20250188081A1 (en) * | 2023-12-08 | 2025-06-12 | Shaman Pharma, LLC | Method for Production of Spiro-Oxindole and Indoxyl Derivatives of Mitragynine |
| WO2025137307A1 (en) | 2023-12-20 | 2025-06-26 | Gasherbrum Bio, Inc. | Heterocyclic glp-1 agonists |
| WO2025154020A1 (en) | 2024-01-19 | 2025-07-24 | Takeda Pharmaceutical Company Limited | Improved gip receptor agonist peptide compounds and uses thereof |
| WO2025154021A1 (en) | 2024-01-19 | 2025-07-24 | Takeda Pharmaceutical Company Limited | Improved gip receptor agonist peptide compounds and uses thereof |
| WO2025171340A1 (en) | 2024-02-08 | 2025-08-14 | Aconcagua Bio, Inc. | The treatment of calcitonin- and/or amylin-receptor associated conditions |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2656610B1 (fr) * | 1989-12-29 | 1992-05-07 | Sanofi Sa | Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique. |
| JP3545461B2 (ja) * | 1993-09-10 | 2004-07-21 | エーザイ株式会社 | 二環式ヘテロ環含有スルホンアミド誘導体 |
| NZ273073A (en) * | 1993-09-10 | 1996-09-25 | Eisai Co Ltd | Bicyclic heterocyclic sulphonamide and sulphonic acid ester derivatives and pharmaceutical compositions thereof |
| WO1997010224A1 (en) | 1995-09-13 | 1997-03-20 | Takeda Chemical Industries, Ltd. | Benzoxazepine compounds, their production and use as lipid lowering agents |
| JP2002504541A (ja) * | 1998-02-25 | 2002-02-12 | ジェネティックス・インスチチュート・インコーポレーテッド | ホスホリパーゼ酵素阻害剤 |
| JP4007743B2 (ja) | 1999-02-26 | 2007-11-14 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 血管新生阻害剤 |
| AR035016A1 (es) | 1999-08-25 | 2004-04-14 | Takeda Chemical Industries Ltd | Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima. |
| GB0003636D0 (en) * | 2000-02-16 | 2000-04-05 | Smithkline Beecham Plc | Novel compounds |
| EP1285651B1 (en) | 2000-04-28 | 2010-09-01 | Takeda Pharmaceutical Company Limited | Melanin concentrating hormone antagonists |
| EP1283199A4 (en) | 2000-05-16 | 2003-12-17 | Takeda Chemical Industries Ltd | MELANINE CONCENTRATING HORMONE ANTAGONISTS |
| PL375149A1 (en) * | 2002-10-03 | 2005-11-28 | F.Hoffmann-La Roche Ag | Indole-3-carboxamides as glucokinase (gk) activators |
| EP1532980A1 (en) * | 2003-11-24 | 2005-05-25 | Novo Nordisk A/S | N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
| US7498445B2 (en) * | 2004-05-05 | 2009-03-03 | Renopharm Ltd. | Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof |
| EP1632491A1 (en) * | 2004-08-30 | 2006-03-08 | Laboratorios Del Dr. Esteve, S.A. | Substituted indole compounds and their use as 5-HT6 receptor modulators |
| US8957070B2 (en) * | 2005-04-20 | 2015-02-17 | Takeda Pharmaceutical Company Limited | Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity |
| WO2007037543A1 (ja) | 2005-09-29 | 2007-04-05 | Banyu Pharmaceutical Co., Ltd. | ビアリールアミド誘導体 |
| AU2006295645B2 (en) | 2005-09-30 | 2011-09-29 | Msd K.K. | 2-heteroaryl-substituted indole derivative |
| PL2188291T3 (pl) * | 2007-08-14 | 2013-06-28 | Bayer Ip Gmbh | Skondensowane bicykliczne pirymidyny |
| PA8793301A1 (es) * | 2007-08-14 | 2009-04-23 | Bayer Schering Pharma Ag | Imidazoles bicíclicos fusionados |
| ES2424023T3 (es) * | 2007-10-18 | 2013-09-26 | Janssen Pharmaceutica N.V. | 1,2,4-triazoles trisustituidos |
| JO2784B1 (en) * | 2007-10-18 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | 5,3,1 - Triazole substitute derivative |
-
2007
- 2007-10-18 NZ NZ576570A patent/NZ576570A/en not_active IP Right Cessation
- 2007-10-18 AU AU2007310064A patent/AU2007310064B2/en not_active Ceased
- 2007-10-18 GE GEAP200711259A patent/GEP20115241B/en unknown
- 2007-10-18 ZA ZA200902585A patent/ZA200902585B/xx unknown
- 2007-10-18 EP EP12170280A patent/EP2508524A3/en not_active Withdrawn
- 2007-10-18 MY MYPI20091549A patent/MY158052A/en unknown
- 2007-10-18 TW TW096138971A patent/TWI460176B/zh not_active IP Right Cessation
- 2007-10-18 JP JP2009515658A patent/JP5260507B2/ja not_active Expired - Fee Related
- 2007-10-18 US US12/311,893 patent/US8410087B2/en not_active Expired - Fee Related
- 2007-10-18 CN CN2007800470664A patent/CN101573357B/zh not_active Expired - Fee Related
- 2007-10-18 RU RU2009118602/04A patent/RU2454415C9/ru not_active IP Right Cessation
- 2007-10-18 ME MEP-118/09A patent/MEP11809A/xx unknown
- 2007-10-18 KR KR1020097010151A patent/KR101444486B1/ko not_active Expired - Fee Related
- 2007-10-18 MX MX2009003972A patent/MX2009003972A/es active IP Right Grant
- 2007-10-18 WO PCT/JP2007/070772 patent/WO2008050821A1/en not_active Ceased
- 2007-10-18 BR BRPI0717722-4A patent/BRPI0717722A2/pt not_active IP Right Cessation
- 2007-10-18 US US11/907,929 patent/US7652133B2/en not_active Expired - Fee Related
- 2007-10-18 CA CA2666973A patent/CA2666973C/en not_active Expired - Fee Related
- 2007-10-18 EP EP07830506A patent/EP2074119A1/en not_active Withdrawn
- 2007-10-18 UA UAA200904957A patent/UA97257C2/ru unknown
-
2008
- 2008-04-10 CL CL2008001017A patent/CL2008001017A1/es unknown
- 2008-04-16 PE PE2008000659A patent/PE20090884A1/es not_active Application Discontinuation
-
2009
- 2009-03-19 US US12/382,622 patent/US7777047B2/en not_active Expired - Fee Related
- 2009-03-19 US US12/382,623 patent/US7718798B2/en not_active Expired - Fee Related
- 2009-04-08 TN TNP2009000129A patent/TN2009000129A1/fr unknown
- 2009-04-16 IL IL198154A patent/IL198154A/en not_active IP Right Cessation
- 2009-04-24 CR CR10748A patent/CR10748A/es unknown
- 2009-05-13 MA MA31871A patent/MA30890B1/fr unknown
- 2009-05-14 EC EC2009009330A patent/ECSP099330A/es unknown
- 2009-05-19 NO NO20091948A patent/NO20091948L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MEP11809A (en) | Indole compound | |
| EA200701176A1 (ru) | Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их | |
| PH12014501033A1 (en) | Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin | |
| TW201000473A (en) | Benzene or thiophene derivative and use thereof as VAP-1 inhibitor | |
| MX2010011217A (es) | Inhibidores de piridilo para señalizacion hedgehog. | |
| BRPI0913457B8 (pt) | Composto e composição farmacêutica | |
| TW200833675A (en) | Nicotinamide derivatives | |
| MX2010009736A (es) | Compuesto heterociclico. | |
| MY153915A (en) | Organic compounds | |
| MX2010005649A (es) | Compuestos novedosos como ligandos del receptor canabinoide y sus usos. | |
| MX2009008779A (es) | Composicion farmacéutica que comprende derivado de pirazina y método para usar el derivado de pirazina en combinación. | |
| SMP201100019B (it) | Composti organici | |
| MX2009000884A (es) | Derivados de piridizinona. | |
| DK2134691T3 (da) | Quinolinonderivativer som parp- og tank-inhibitorer | |
| PH12013500745A1 (en) | Azaadamantane derivatives and methods of use | |
| UA105185C2 (uk) | Піроли | |
| IN2012DN00869A (enExample) | ||
| UA94944C2 (ru) | 2,4-диаминопиримидины как ингибиторы киназ, которые принимают участие в регуляции клеточного цикла | |
| NO20081217L (no) | Nye benzotiazolonderivater | |
| MX2010008460A (es) | Derivado de tiazol y su uso como inhibidor de proteina-1 de adhesion vascular. | |
| EA200601391A1 (ru) | Производные хинолина для применения в качестве микобактериальных ингибиторов | |
| CY1115247T1 (el) | Ενωσεις συμπυκνωμενων δακτυλιων και χρηση αυτων | |
| ATE517873T1 (de) | 6-oxo-1,6-dihydropyrimidin-2-yle bei der behandlung proliferativer krankheiten | |
| MY158069A (en) | Tricyclic compound and pharmaceutical use thereof | |
| UA106200C2 (uk) | Заміщені похідні оксіндолу та їхнє застосування для лікування захворювань, залежних від вазопресину |